Levocabastine

Levocabastine: Overview

Levocabastine is a synthetic phenylpiperidine derivative belonging to the second-generation selective histamine H1 receptor antagonist chemical class used as an antiallergic medication. It is administered topically as a sterile ophthalmic suspension or nasal spray under brand names like Livostin to competitively inhibit histamine H1 receptors, block allergic inflammatory responses, and relieve ocular itching, redness, tearing, and nasal congestion in patients with seasonal allergic conjunctivitis and allergic rhinitis.

What Is Levocabastine & How Does It Work?

Levocabastine is a second-generation antihistamine. Allergens trigger mast cell degranulation in conjunctival and nasal mucosa, releasing histamine that binds H1 receptors on endothelial cells and nerve endings, causing itching, vasodilation, tearing, and congestion.

Levocabastine works through selective H1 receptor antagonism, neurotensin receptor modulation, and vascular permeability inhibition. Following application, Levocabastine diffuses into mucosal surface tissues and binds H1 receptors, competitively blocking histamine. While it does not prevent histamine release, blocking H1 activation halts vasodilation, fluid extravasation, and sensory nerve stimulation. Additionally, Levocabastine acts as a partial antagonist at neurotensin receptor type 2, providing mild localized analgesia.

Is Levocabastine FDA Approved?

Levocabastine received US FDA approval in November 1993 as a prescription ophthalmic suspension for relieving seasonal allergic conjunctivitis.

The FDA approved Levocabastine hydrochloride 0.05 percent suspension under the brand name Livostin for relieving ocular itching, swelling, and redness. Although US commercial distribution of Livostin was discontinued, Levocabastine remains an approved entity. Levocabastine is classified as FDA Approved.

What Is Levocabastine Used For?

Relief of signs and symptoms of seasonal allergic conjunctivitis, including itching and redness (FDA Approved). Symptomatic treatment of allergic rhinitis and nasal congestion using nasal spray formulations (FDA Approved). Prophylactic reduction of ocular allergic inflammation prior to allergen exposure (FDA Approved). Management of giant papillary conjunctivitis associated with contact lens wear (Off-label use). Relief of localized allergic dermatoses in topical combination gels (Off-label use). Research evaluating neurotensin receptor type 2 binding kinetics (Unapproved; research use).

Before Taking Levocabastine: Contraindications & Precautions

Evaluating ocular surface integrity, contact lens usage, renal status, and hypersensitivity history is essential before administering Levocabastine. Specific pre-existing clinical conditions strictly preclude the use of Levocabastine.

Who Should Not Take Levocabastine?

Levocabastine is contraindicated in patients with severe hypersensitivity to Levocabastine or formulation components. It is strictly contraindicated in patients with severe hypersensitivity to benzalkonium chloride, a preservative in ophthalmic suspensions that can cause ocular irritation.

Levocabastine: Pregnancy & Fertility

Animal reproduction studies evaluating oral Levocabastine demonstrated embryo-fetal toxicity at high doses. Levocabastine should be used during pregnancy only when clinical benefits justify potential fetal risks. Systemic absorption following topical use is minimal, but small amounts cross into human milk. Caution is advised when administering to nursing mothers. Fertility studies demonstrate no documented reproductive impairment.

Tell Your Doctor Before Taking Levocabastine

Tell your physician if you have a history of dry eye syndrome, corneal defects, or active ocular surface infections. Disclose pre-existing renal or hepatic impairment. Inform your doctor if you wear contact lenses or use other eye drops. Disclose concurrent medications, particularly oral antihistamines, sedatives, or QTc-prolonging agents.

Levocabastine: Dosage & Administration

Proper administration and dosage depend on the route of administration, infection type, and strict adherence to bottle shaking protocols. Strict adherence to administration guidelines prevents drop contamination.

Standard Levocabastine Dosing

For adults and pediatric patients 4 years of age and older with seasonal allergic conjunctivitis, standard ophthalmic dosing is 1 drop of Levocabastine 0.05 percent suspension in affected eyes 4 times daily. For adults and children 6 years of age and older with allergic rhinitis, standard nasal dosing is 2 sprays of Levocabastine 0.05 mg per actuation nasal suspension per nostril 2 to 4 times daily.

How Levocabastine Is Administered

Levocabastine is supplied as a sterile 0.05 percent ophthalmic suspension or nasal spray. Shake the bottle thoroughly before each use. Wash hands, tilt head back, pull down the lower eyelid, and instill 1 drop into the lower conjunctival sac without touching the dropper tip to any surface. Apply pressure to the inner eye corner for 1 to 2 minutes after instillation. Remove soft contact lenses before instillation and wait 10 minutes before reinserting.

Levocabastine: Clinical Efficacy & Research

Clinical trials established that topical Levocabastine 0.05 percent ophthalmic suspension provides rapid relief of ocular itching within 5 to 15 minutes following instillation, with efficacy lasting up to 4 hours. Research confirmed that Levocabastine is a potent second-generation H1 antagonist with high receptor selectivity, minimizing anticholinergic side effects. Studies demonstrated that Levocabastine nasal spray significantly reduces nasal resistance and sneezing in allergic rhinitis.

Levocabastine: Side Effects & Safety Profile

Clinical use of Levocabastine requires monitoring for localized ocular surface stinging, transient headache, and rare systemic hypersensitivity across short-term and extended allergy seasons.

Common Levocabastine Side Effects

Localized ocular symptoms including transient burning, stinging, ocular discomfort, dry eyes, and eyelid edema. Neurological symptoms including mild headache, somnolence, fatigue, and dizziness. Respiratory and nasal symptoms including nasal irritation, dryness, epistaxis, and pharyngolaryngeal pain. Gastrointestinal symptoms including mild nausea, altered taste sensation, and dry mouth.

Serious Levocabastine Adverse Events

Severe acute hypersensitivity reactions, including facial angioedema, urticaria, bronchospasm, and dyspnea. Corneal epithelial toxicity, corneal punctate keratitis, and conjunctival hyperemia secondary to preservative exposure. Potential cardiac conduction effects, including QTc interval prolongation in rare instances of high exposure. Secondary ocular infection resulting from contamination of the dropper tip.

Managing Levocabastine Side Effects

If mild burning or stinging occurs upon drop instillation, keep eyes gently closed for 1 minute and apply nasolacrimal pressure. If severe eye pain, vision changes, persistent corneal irritation, or signs of allergy develop, discontinue Levocabastine immediately and seek medical evaluation. Manage dry eyes with preservative-free artificial tears spaced 15 minutes apart.

Levocabastine: Interactions & What to Avoid

Levocabastine creates potential for drug interactions when combined with central nervous system depressants or QTc-prolonging agents. Safe administration requires screening co-administered medications.

Levocabastine: Interactions

Co-administration of Levocabastine with oral sedatives, alcohol, or central nervous system depressants may produce additive somnolence in sensitive individuals. Co-administration with systemic QTc-prolonging drugs requires caution, though systemic absorption following topical use is low. Separate different topical eye drop instillations by 5 to 10 minutes.

Levocabastine: Food & Alcohol

Topical ophthalmic and nasal administration of Levocabastine is not affected by oral food intake. Alcohol consumption should be avoided or limited during Levocabastine therapy, as alcohol can compound central nervous system somnolence.

Levocabastine: Missed Dose, Overdose & Storage

Strict adherence to daily application schedules and proper environmental storage maintains product stability and prevents toxicity. Clear guidelines for handling missed doses or accidental overdoses ensure patient safety.

Missed Dose of Levocabastine

If a dose of Levocabastine is missed, apply the drop or spray as soon as remembered on that day. If it is almost time for the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double doses.

Levocabastine: Overdose & Emergency

Accidental oral ingestion of Levocabastine suspension may cause drowsiness, sedation, tachycardia, and mild hypotension. In case of accidental oral ingestion or ocular overdose, flush eyes with saline or water, seek medical evaluation, or contact poison control.

How to Store Levocabastine

Store Levocabastine ophthalmic suspension and nasal spray containers at room temperature between 15 degrees Celsius and 25 degrees Celsius (59 degrees Fahrenheit to 77 degrees Fahrenheit). Keep containers tightly closed, protected from direct light, heat, and freezing. Store out of reach of children.

Levocabastine: Patient Management & Monitoring

Routine patient evaluation and ocular surface monitoring optimize antiallergic outcomes while safeguarding patient safety throughout allergy seasons.

Tests Before Starting Levocabastine

Pre-treatment ophthalmic examination, including slit-lamp evaluation of the cornea and conjunctiva. Pre-treatment screening for active viral, bacterial, or fungal ocular surface infections. Baseline evaluation of dry eye status and contact lens hygiene habits.

Monitoring During Levocabastine Treatment

Periodic clinical evaluation of ocular itching and conjunctival redness resolution during allergy season. Slit-lamp evaluation of corneal epithelial surface integrity during extended therapy. Monitoring for signs of localized contact dermatitis or preservative-related irritation.

Levocabastine: Do’s and Don’ts

Do shake the bottle thoroughly before each application to ensure proper drug suspension. Do apply gentle pressure to the inner corner of the eye for 1 minute after instilling drops. Don’t touch the dropper tip to your eye, fingers, or any surface to maintain sterility. Don’t wear soft contact lenses while eyes are red or during active allergic conjunctivitis episodes.

Frequently Asked Questions

References

Official FDA Prescribing Information: Livostin (Levocabastine Hydrochloride Ophthalmic Suspension 0.05 Percent), Application No. NDA 020216. DrugBank Online: Levocabastine (DB01106) Profile and Pharmacological Data. National Center for Biotechnology Information (NCBI) PubChem Compound Summary: Levocabastine.

Legal Disclaimer

The information provided is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or clinic before starting or stopping any medication.